HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mitsugu Sekimoto Selected Research

Active Hexose Correlated Compound

2/2022Efficacy of active hexose correlated compound on survival of patients with resectable/borderline resectable pancreatic cancer: a study protocol for a double-blind randomized phase II study.
11/2021Nutritional impact of active hexose-correlated compound for patients with resectable or borderline-resectable pancreatic cancer treated with neoadjuvant therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mitsugu Sekimoto Research Topics

Disease

114Neoplasms (Cancer)
04/2024 - 11/2002
48Colorectal Neoplasms (Colorectal Cancer)
10/2023 - 06/2002
46Neoplasm Metastasis (Metastasis)
04/2024 - 06/2002
30Rectal Neoplasms (Rectal Cancer)
02/2024 - 10/2003
23Stomach Neoplasms (Stomach Cancer)
12/2021 - 01/2003
17Lymphatic Metastasis
10/2023 - 06/2002
15Hepatocellular Carcinoma (Hepatoma)
05/2023 - 05/2003
14Adenocarcinoma
12/2023 - 08/2003
13Colonic Neoplasms (Colon Cancer)
01/2018 - 05/2005
11Pancreatic Neoplasms (Pancreatic Cancer)
03/2024 - 03/2008
9Breast Neoplasms (Breast Cancer)
01/2024 - 01/2010
9Carcinoma (Carcinomatosis)
06/2023 - 03/2008
8Hemorrhage
08/2021 - 11/2003
7Triple Negative Breast Neoplasms
06/2022 - 01/2020
5Inflammation (Inflammations)
01/2024 - 01/2022
5Cholangiocarcinoma
01/2023 - 04/2010
5Esophageal Neoplasms (Esophageal Cancer)
04/2021 - 01/2008
5Diarrhea
01/2021 - 11/2006
5Venous Thromboembolism
09/2019 - 11/2014
4Ischemia
05/2024 - 07/2021
4Reperfusion Injury
05/2024 - 12/2022
4Hypoxia (Hypoxemia)
01/2022 - 04/2006
4Pain (Aches)
01/2022 - 10/2003
4Neutropenia
05/2016 - 01/2013
3Sepsis (Septicemia)
01/2023 - 01/2022
3Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2023 - 08/2006
3Anemia
01/2023 - 12/2018
3Postoperative Pain
11/2022 - 10/2013
3Pathologic Constriction (Stenosis)
11/2022 - 04/2021
3Sigmoid Neoplasms
12/2019 - 11/2010
3Wounds and Injuries (Trauma)
12/2019 - 11/2003
3Margins of Excision
10/2019 - 01/2012
3Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
11/2016 - 03/2008
3Thrombosis (Thrombus)
05/2009 - 02/2005
3Adenoma (Adenomas)
02/2008 - 11/2002

Drug/Important Bio-Agent (IBA)

18Proteins (Proteins, Gene)FDA Link
04/2022 - 06/2002
16Irinotecan (Camptosar)FDA LinkGeneric
12/2018 - 10/2004
11Messenger RNA (mRNA)IBA
01/2024 - 08/2003
10Indicators and Reagents (Reagents)IBA
01/2023 - 01/2004
9Leucovorin (Folinic Acid)FDA Link
01/2018 - 10/2005
8Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2023 - 08/2005
7GemcitabineFDA Link
07/2023 - 01/2018
7Bevacizumab (Avastin)FDA Link
09/2021 - 01/2013
6Paclitaxel (Taxol)FDA LinkGeneric
01/2024 - 08/2005
6Biomarkers (Surrogate Marker)IBA
11/2022 - 12/2006
6Fondaparinux (Arixtra)FDA Link
09/2019 - 11/2014
6TegafurIBA
01/2018 - 01/2006
5Cisplatin (Platino)FDA LinkGeneric
01/2022 - 11/2016
5Fluorouracil (Carac)FDA LinkGeneric
01/2018 - 10/2005
5UracilIBA
01/2018 - 01/2006
4RNA (Ribonucleic Acid)IBA
09/2022 - 02/2004
4Trastuzumab (Herceptin)FDA Link
12/2018 - 11/2014
3LigandsIBA
01/2024 - 04/2022
3C-Reactive ProteinIBA
07/2023 - 10/2013
3AlbuminsIBA
07/2023 - 04/2022
3Immune Checkpoint InhibitorsIBA
02/2023 - 09/2021
3CarbohydratesIBA
01/2023 - 05/2012
3BilirubinIBA
10/2022 - 11/2011
3Anti-Bacterial Agents (Antibiotics)IBA
06/2022 - 11/2014
3Fatty Acids (Saturated Fatty Acids)IBA
04/2022 - 02/2010
3Perilipin-2IBA
04/2022 - 01/2020
3130-nm albumin-bound paclitaxelIBA
02/2022 - 01/2018
3B7-H1 AntigenIBA
03/2021 - 01/2021
3Capecitabine (Xeloda)FDA Link
12/2019 - 02/2008
3AnticoagulantsIBA
09/2019 - 02/2005
3Carcinoembryonic AntigenIBA
01/2016 - 06/2002
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2011 - 02/2004
3Calcibiotic Root Canal SealerIBA
11/2010 - 02/2008
3Complementary DNA (cDNA)IBA
12/2008 - 01/2007
3Cyclin D1IBA
08/2006 - 11/2002
2EnzymesIBA
05/2024 - 04/2022
2Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
01/2024 - 01/2023
2CytokinesIBA
01/2024 - 12/2022
2Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2024 - 01/2021
2Photosensitizing Agents (Photosensitizers)IBA
01/2024 - 09/2022

Therapy/Procedure

51Therapeutics
04/2024 - 10/2002
49Drug Therapy (Chemotherapy)
04/2024 - 08/2006
17Neoadjuvant Therapy
03/2024 - 01/2011
16Gastrectomy
08/2021 - 01/2003
15Adjuvant Chemotherapy
06/2022 - 10/2004
14Hepatectomy
05/2024 - 12/2010
14Lymph Node Excision (Lymph Node Dissection)
01/2023 - 01/2003
11Radiotherapy
07/2023 - 11/2006
8Laparotomy
12/2023 - 09/2014
8Pancreatectomy
11/2022 - 11/2015
7Combination Drug Therapy (Combination Chemotherapy)
01/2022 - 10/2004
6Pancreaticoduodenectomy
11/2022 - 11/2015
5Colectomy
10/2023 - 04/2014
4Heavy Ion Radiotherapy
02/2024 - 01/2016
4Chemoradiotherapy
07/2023 - 11/2016
4Aftercare (After-Treatment)
06/2022 - 11/2014
4Combined Modality Therapy
02/2022 - 11/2015
4Pelvic Exenteration
01/2022 - 11/2011
4Operative Surgical Procedures
08/2021 - 01/2017
4Proctectomy
11/2017 - 10/2003
3Immunotherapy
06/2022 - 02/2010
3Segmental Mastectomy (Lumpectomy)
03/2020 - 11/2016
3Oral Administration
12/2018 - 03/2010
3Restorative Proctocolectomy
11/2016 - 03/2008
3Splenectomy
05/2009 - 02/2005